Skip to main content
Clinical Trials/NCT05772247
NCT05772247Not yet recruitingNot Applicable

Predictive Value of PS Application in Premature Infants With RDS by Different Pulmonary Ultrasound Scores: a Prospective Multicenter Study

The First Hospital of Jilin University0 sites1,392 target enrollmentStarted: April 1, 2023Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
1,392
Primary Endpoint
Whether the patient uses ps (pulmonary surfactant)

Study Overview

Brief Summary

A multicenter prospective study was conducted to compare the predictive value of 6-zone, 10-zone, and 12-zone LUS scores for PS application in early and late preterm infants.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
1 Day to 1 Month (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Hospital admission within 2 hours after birth;
  • The diagnosis was RDS;
  • Parents agree to attend

Exclusion Criteria

  • chromosomal abnormalities or complex congenital malformations;
  • congenital pulmonary disease;
  • severe sepsis, disseminated intravascular coagulation, septic shock and other critical conditions;
  • LUS and blood gas analysis have been examined before the application of alveolar surfactant.

Outcomes

Primary Outcomes

Whether the patient uses ps (pulmonary surfactant)

Time Frame: 2023.2-2023.12

The standards used by PS are based on the European consensus

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Similar Trials